Relationship between pp65 antigenemia levels and real-time quantitative DNA PCR for Human Cytomegalovirus (HCMV) management in immunocompromised patients
2007

Monitoring HCMV in Immunocompromised Patients

Sample size: 156 publication Evidence: moderate

Author Information

Author(s): Cariani Elisabetta, Pollara Caterina P, Valloncini Barbara, Perandin Francesca, Bonfanti Carlo, Manca Nino

Primary Institution: Department of Experimental and Applied Medicine, Section of Microbiology, University of Brescia, and A.O. Spedali Civili, Brescia, Italy

Hypothesis

What is the relationship between HCMV DNA levels and pp65 antigenemia in immunocompromised patients?

Conclusion

Both pp65 antigenemia and HCMV DNA load can be useful for monitoring immunocompromised patients, with specific cut-off levels needed for effective treatment.

Supporting Evidence

  • HCMV DNA was detected in 106 samples, while pp65 antigen was found in only 3 samples.
  • The cut-off HCMV DNA level that best predicted pp65 antigenemia was 11,500 copies/ml.
  • HCMV disease was observed in 5 out of 48 patients with active HCMV infection.

Takeaway

Doctors can check for a virus called HCMV in sick patients using two tests, and they need to know the right levels to decide when to start treatment.

Methodology

475 blood samples from 156 immunosuppressed patients were tested for HCMV using pp65 antigenemia and real-time PCR.

Potential Biases

Potential bias in sample selection and interpretation of results due to the nature of the tests used.

Limitations

The study may not generalize to all patient populations due to specific demographics and sample sizes.

Participant Demographics

156 immunosuppressed patients (100 males, 56 females, mean age 44.4 years).

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1186/1471-2334-7-138

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication